Tests in

H3F3A Mutation Analysis

  • Test Code:
    4810
  • Department:
    Solid Tumors
  • Test Synonyms:
    Histone H3.3
View Test

Hearing Loss Panel

  • Test Code:
    1495
  • Department:
    Molecular Genetics
  • Test Synonyms:
    Hearing loss • Deafness • Hearing impairment • Deaf • A2ML1 • ABHD12 • ABHD5 • ACOX1 • ACTB • ACTG1 • ADCY1 • AIFM1 • ALMS1 • ANKH • AP1B1 • ARSB • ARSG • ASIC5 • ATOH1 • ATP11A • ATP1A3 • ATP2B2 • ATP6V1B1 • BSC1L • BDP1BSND • BTD • C10ORF2 • CABP2 • CACNA1D • CATSPER2 • CCDC50 • CD164 • CDC14A • CDH23 • CDKN1C • CEACAM16 • CEP250 • CEP78 • CHD7 • CIB2 • CISD2 • CLDN14 • CLDN9 • CLIC5 • CLPP • CLRN1 • CLRN2 • COCH • COL11A1 • COL11A2 • COL1A1 • COL2A1 • COL4A3 • COL4A4 • COL4A5 • COL4A6 • COL9A1 • COL9A2 • CRYM • DCDC2 • DFNA5 • DFNB31 • DFNB59 • DIABLO • DIAPH1 • DIAPH3 • DLX5 • DMXL2 • DNAJC3 • DNMT1 • DSPP • DTNA • EDN3 • EDNRB • ELMOD3 • EPS8 • EPS8L2 • ERAL1 • ESPN • ESRRB • EYA1 • EYA4 • FAM65B • FDXR • FGF3 • FGFR3 • FITM2 • FOXC1 • FOXI1 • GATA3 • GIPC3 • GJB2 • GJB3 • GJB6 • GPR98 • GPRASP2 • GPSM2 • GRAP • GREB1L • GRHL2 • GRXCR1 • GRXCR2 • HARS • HARS2 • HGF • HOMER2 • HOXA2 • HSD17B4 • IFNLR1 • ILDR1 • KARS • KCNE1 • KCNJ10 • KCNQ1 • KCNQ4 • KITLG • LARS2 • LHFPL5 • LMX1A • LOXHD1 • LRTOMT • MAFB • MAP1B • MARVELD2 • MASP1 • MCM2 • MEPE • MET • MIR96 • MITF • MPZL2 • MRPS2 • MTRNR1 • MYH14 • MYH9 • MYO15A • MYO3A • MYO6 • MYO7A • NARS2 • NDP • NLRP3 • NOG • OPA1 • OSBPL2 • OTOA • OTOF • OTOG • OTOGL • P2RX2 • PAX3 • PCDH15 • PDE1C • PDZD7 • PEX1 • PEX26 • PEX6 • PITX2 • PLS1 • PLS3 • PNPT1 • POLR1C • POLR1D • POU3F4 • POU4F3 • PRKCB • PRPS1 • PTPRQ • RAI1 • RDX • REEP6 • REST • ROR1 • RPS6KA3 • S1PR2 • SALL1 • SALL4 • SEMA3E • SERPINB6 • SIX1 • SIX2 • SIX5 • SLC17A8 • SLC19A2 • SLC22A4 • SLC26A4 • SLC26A5 • SLC29A3 • SLC44A4 • SLC52A2 • SLC9A1 • SLITRK6 • SMPX • SNAI2 • SOX10 • SPNS2 • STRC • SYNE4 • TBC1D24 • TBX1 • TCOF1 • TECTA • TIMM8A • TJP2 • TMC1 • TMEM126A • TMEM132E • TMEM43 • TMIE • TMPRSS3 • TNC • TPRN • TRIOBP • TRMT10C • TRRAP • TSHZ1 • TSPEAR • TUBB4B • USH1C • USH1G • USH2A • WBP2 • WFS1 • XYLT2
View Test

Heme/Onc Blood: Full Chromosome Study reflexed to FISH

  • Test Code:
    6300
  • Department:
    Cancer Cytogenetics
  • Test Synonyms:
    Chromosomes • Cancer Blood • Hematological Malignancies • Heme/onc blood • Heme-onc blood
View Test

HER-2 (ERBB2) FISH

  • Test Code:
    8300
  • Department:
    Cancer FISH
  • Test Synonyms:
    HER2 • HER-2/neu • ERBB2 (17q12-q12)
View Test

Hereditary Hemochromatosis (HFE), Common Variants

  • Test Code:
    1600
  • Department:
    Molecular Genetics
  • Test Synonyms:
    HFE • HLA-H Mutation, PCR • Iron, Tissue, DNA Test (Hemochromatosis) • C282Y • H63D
View Test

Herpes Simplex Virus 1 & 2 PCR

  • Test Code:
    3330
  • Department:
    Infectious Disease
  • Test Synonyms:
    Qualitative HSV with subtyping • HSV-1 • HSV-2
View Test

Heterotaxia Panel

  • Test Code:
    1610
  • Department:
    Molecular Genetics
  • Test Synonyms:
    Heterotaxy Syndrome • ACVR2B • ARMC4 • C21ORF59 • CCDC103 • CCDC114 • CCDC151 • CCDC39 • CCDC40 • CCDC65 • CCNO • CENPF • CITED2 • CRELD1 • DNAAF1 • DNAAF2 • DNAAF3 • DNAH11 • DNAH5 • DNAI1 • DNAI2 • DNAJB13 • DRC1 • DYX1C1 • FOXH1 • GAS8 • GATA4 • GDF1 • HEATR2 • LEFTY2 • LRRC6 • NKX2-5 • NODAL • PIH1D3 • RSPH1 • RSPH3 • RSPH4A • RSPH9 • SHROOM3 • SMAD2 • SPAG1 • ZIC3 • ZMYND10
View Test

High HDL Panel

  • Test Code:
  • Department:
    Molecular Genetics
  • Test Synonyms:
    Hypoalphalipoproteinemia • Cholesteryl ester Transferase Deficiency • CETP deficiency
View Test

Holoprosencephaly Panel

  • Test Code:
    1625
  • Department:
    Molecular Genetics
  • Test Synonyms:
    HPE • CDON • DISP1 • DLL1 • FGF8 • FGFR1 • FOXH1 • GAS1 • GLI2 • NODAL • PTCH1 • SHH • SIX3 • TGIF1 • ZIC2
View Test

Huntington Disease

  • Test Code:
    1620
  • Department:
    Molecular Genetics
  • Test Synonyms:
    HD • Huntington’s Chorea • HTT
View Test
Innovations in Testing
View All Tests

The Knight Cancer Institute at Oregon Health & Science University is a pioneer in the field of precision cancer medicine. The institute's director, Brian Druker, M.D., helped prove it was possible to shut down just the cells that enable cancer to grow. This breakthrough has made once-fatal forms of the disease manageable and transformed how cancer is treated. The OHSU Knight Cancer Institute is the only National Cancer Institute-designated Cancer Center between Sacramento and Seattle – an honor earned only by the nation's top cancer centers. It is headquarters for one of the National Cancer Institute's largest research collaboratives, SWOG, in addition to offering the latest treatments and technologies as well as hundreds of research studies and clinical trials.

Learn More